Cue Biopharma (CUE) Shares Outstanding (Weighted Average) (2017 - 2025)

Cue Biopharma has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $20.5 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $20.5 million, down 63.54% year-over-year; the trailing twelve-month figure through Dec 2025 was $20.5 million (down 63.54% YoY), and the FY2025 annual result was $20.5 million, up 244.36% from the prior year.
• Shares Outstanding (Weighted Average) came in at $20.5 million for Q4 2025 at Cue Biopharma, down from $12435.6 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $12435.6 billion in Q1 2024 to a low of $789358.0 in Q3 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $32.0 million (2021), against an average of $1865.4 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) surged 116005288.51% in 2024 and sank 100.0% in 2025, its largest moves.
• Cue Biopharma's Shares Outstanding (Weighted Average) stood at $31.3 million in 2021, then climbed by 13.95% to $35.6 million in 2022, then rose by 28.35% to $45.8 million in 2023, then rose by 23.11% to $56.3 million in 2024, then tumbled by 63.54% to $20.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $20.5 million (Q4 2025), $12435.6 billion (Q3 2025), and $12435.6 billion (Q2 2025), per Business Quant data.